mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.002 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |